# An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Systemic Lupus Erythematosus

- Company: AstraZeneca
- Sector: Systemic Lupus Erythematosus
- Primary source: https://clinicaltrials.gov/study/NCT05835310

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.